• Aucun résultat trouvé

Pemphigoïde cicatricielle (MMP DAI score)

N/A
N/A
Protected

Academic year: 2022

Partager "Pemphigoïde cicatricielle (MMP DAI score)"

Copied!
2
0
0

Texte intégral

(1)

Pemphigoïde cicatricielle (MMP DAI score)

Source :

Murrell DF, Marinovic B, Caux F, Prost C, Ahmed R, Wozniak K, Amagai M, Bauer J, Beissert S, Borradori L, Culton D, Fairley JA, Fivenson D, Jonkman MF, Marinkovich MP, Woodley D, Zone J, Aoki V, Bernard P, Bruckner-Tuderman L, Cianchini G, Venning V, Diaz L, Eming R, Grando SA, Hall RP, Hashimoto T, Herrero-González JE, Hertl M, Joly P, Karpati S, Kim J, Chan Kim S, Korman NJ, Kowalewski C, Lee SE, Rubenstein DR, Sprecher E, Yancey K, Zambruno G, Zillikens D, Doan S, Daniel BS, Werth VP.

D EFINITIONS AND OUTCOME MEASURES FOR MUCOUS MEMBRANE PEMPHIGOID :

RECOMMENDATIONS OF AN INTERNATIONAL PANEL OF EXPERTS . J Am Acad Dermatol 2015;72:168-74

Validé le 10 sept. 2015 par P. Joly (Groupe Bulles de la SFD)

(2)

Pemphigoïde cicatricielle (MMP DAI score)

Mucous Membrane Pemphigoid Disease Area Index (MMP DAI score)

Skin Activity Damage

Scalp

1 Scalp Erosion/Blisters or new erythema

Number lesions if 3

Post-inflammatory hyperpigmentation or erythema from resolving lesion

2

3 0 absent 4 1 in one quadrant 5 2 two quadrants 6 3 three quadrants 7 4 affects whole skull 10 at least one lesion > 6 cm

0 absent 1 present 8

9 Total Scalp (0-10) 10 /10 /1

Mucous membranes

Anatomical Location Erosion/Blisters/active erythema

Post-inflammatory hyperpigmentation or erythema from resolving lesion or scarring

Eyes

0 No erythema 1 Light pink 2 Moderate pink 3 Dark pink 4 Bright red add up quadrants

0 absent 1 present

Left eye (0-16) x 0.625 Right eye (0-16) x 0.625

0 absent 1 1 lesion 2 2--3 lesions 5 >3 lesions or 2 lesions >2 cm 10 entire area

Number lesions if 3

0 absent 1 present

11 Nasal

12 Buccal mucosa

Palate

Upper gingiva

Lower gingiva

Tongue/Floor of mouth

Labial

Posterior pharynx

Anal

Genital

Total Mucosa /120 /12

Total Activity Score: Total Damage Score

Anatomical Location Erosion/Blisters or new erythema Post-inflammatory hyperpigmentation or erythema from resolving lesion or scarring 0 absent

1 1-3 lesions, up to one >2 cm in any diameter, none > 6 cm

2 2-3 lesions, at least two > 2 cm diameter, none >

6cm

3 >3 lesions, none > 6 cm diameter 5 >3 lesions, and/or at least one >6 cm 10 >3 lesions, and/or at least one lesion >16 cm

diameter or entire area

Number lesions if 3

0 absent 1 present

Ears

Forehead

Rest of the face

Neck

Chest

Abdomen

Shoulders, Back

Buttocks

Arms & hands

Legs & feet

Anal

Genitals

Total skin /120 /12

Références

Documents relatifs

Based on a content analysis of 83 documents from 42 inter/-nongovernmental, global and regional organisations involved in international education networks between 1990 and 2015,

Margaret Fitch (Bloomberg Faculty of Nursing, University of Toronto, Canada) summarized how the interest in patient reported out- comes has been growing in cancer care over the

U nderstanding and communicating risk, such as the magnitude or effect size of the benefts and harms associated with preventive screening and other health care

Herlitz junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the gamma 2 subunit of nicein/kalinin (LAMININ- 5).. Autosomal dominant junctional

To our knowledge, no case of OMMP or bullous pem- phigoid induced by gliclazide has so far been reported. Our patient is the first case of glicazide-induced OMMP, not associated

However, we recently showed that BP was associated with the production of IL-23 and CXCL10, two markers of the M1 macrophage phenotype (17–19), thus further questioning on the

Major Basic Protein (MBP) (A), Eosinophil Derived Neurotoxin (EDN) (B) and Eosinophil Cationic Protein (ECP) (C) serum levels from 61 patients with active bullous pemphigoid and

Measures implemented to control or affect the prices of imported goods in order to, inter alia, support the domestic price of certain products when the